The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 30, 2017

Filed:

Oct. 24, 2013
Applicant:

The Charlotte-mecklenburg Hospital Authority, Charlotte, NC (US);

Inventors:

Herbert L. Bonkovsky, Charlotte, NC (US);

David Foureau, Charlotte, NC (US);

H. James Norton, Charlotte, NC (US);

Nury Steuerwald, Charlotte, NC (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); G01N 2333/49 (2013.01); G01N 2333/503 (2013.01); G01N 2333/523 (2013.01); G01N 2333/525 (2013.01); G01N 2333/54 (2013.01); G01N 2333/5406 (2013.01); G01N 2333/5409 (2013.01); G01N 2333/5412 (2013.01); G01N 2333/5425 (2013.01); G01N 2333/5434 (2013.01); G01N 2333/5437 (2013.01); G01N 2333/765 (2013.01); G01N 2800/08 (2013.01); G01N 2800/085 (2013.01); G01N 2800/52 (2013.01); G01N 2800/60 (2013.01);
Abstract

Methods and kits for characterizing liver damage in an individual are provided. The methods employ the use of immune analytes as biomarkers for detecting liver damage and predicting the likelihood that an individual suffering from liver damage will experience life-threatening liver failure. Concentration values for serum albumin and other identified immune analytes are obtained or determined from a blood sample taken from the individual. The obtained concentration values are then compared to corresponding concentrations from individuals having a healthy liver. By comparing the concentrations, an individual's likelihood of developing life-threatening liver failure and needing a liver transplant within a given time period (e.g., 6 months) can be identified.


Find Patent Forward Citations

Bonkovsky, Herbert. (2017). Biomarkers for the identification of liver damage (U.S. Patent No. 9664693). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9664693

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…